CVS (NYSE:CVS) has announced that in order to sharpen its focus on the health of its customers it will cease selling tobacco products by October of this year. The move will cost the company billions in sales, but could it cost the tobacco industry even more if other companies follow CVS' lead?

In this segment of the Motley Fool's consumer goods show, Consumer Countdown, CG analyst Michael Finarelli joins host Mark Reeth to discuss what lies ahead for CVS and if the company is about to take down Big Tobacco.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.